Cargando…

Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine

BACKGROUND: Pancreatic cancer is a common, highly lethal disease with a rising incidence. MUC1 is a tumor-associated antigen that is over-expressed in pancreatic adenocarcinoma. Active immunotherapy that targets MUC1 could have great treatment value. Here we investigated the preventive and therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rong, Yefei, Jin, Dayong, Wu, Wenchuan, Lou, Wenhui, Wang, Danshong, Kuang, Tiantao, Ni, Xiaoling, Qin, Xinyu
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702393/ https://www.ncbi.nlm.nih.gov/pubmed/19534821 http://dx.doi.org/10.1186/1471-2407-9-191

Ejemplares similares

PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Wang, Huanyu, et al.
Publicado: (2022)

Granulocytic sarcoma of the pancreas: A case report and review of the literatures
por: Rong, Yefei, et al.
Publicado: (2010)

Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center
por: Rong, Yefei, et al.
Publicado: (2017)

GFAT1 is highly expressed in cancer stem cells of pancreatic cancer
por: Wang, Zhe, et al.
Publicado: (2022)

Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2
por: Rong, Yefei, et al.
Publicado: (2010)

Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis
por: Xu, Yaolin, et al.
Publicado: (2022)

The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms
por: Zhou, Wentao, et al.
Publicado: (2017)

Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction
por: Pu, Ning, et al.
Publicado: (2019)

Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer
por: Han, Xu, et al.
Publicado: (2017)

Primary small cell carcinoma of the pancreas: rare type of pancreatic cancer and review of the literatures
por: Wang, Dansong, et al.
Publicado: (2012)

CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer
por: Pu, Ning, et al.
Publicado: (2018)

Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis
por: Zhou, Wentao, et al.
Publicado: (2019)

Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
por: Yin, Hanlin, et al.
Publicado: (2021)

Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy?
por: Wu, Wenchuan, et al.
Publicado: (2014)

Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology
por: Han, Xu, et al.
Publicado: (2018)

HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer
por: Fang, Yuan, et al.
Publicado: (2020)

DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1‐mediated antioxidant effects
por: Rong, Yefei, et al.
Publicado: (2020)

Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

Downregulated expression of RACK1 results in pancreatic cancer growth and metastasis
por: Zhang, Lei, et al.
Publicado: (2019)

Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection
por: Pu, Ning, et al.
Publicado: (2017)

The Value of Alkaline Phosphatase-to-Albumin Ratio in Detecting Synchronous Metastases and Predicting Postoperative Relapses among Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreas
por: Pu, Ning, et al.
Publicado: (2022)

Comprehensive Diagnostic Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy
por: Li, Bo, et al.
Publicado: (2021)

Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma
por: Chen, Qiangda, et al.
Publicado: (2022)

Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
por: Senapati, Shantibhusan, et al.
Publicado: (2011)

Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model
por: Wu, Guang, et al.
Publicado: (2022)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
por: Chen, Qiangda, et al.
Publicado: (2020)

A Novel Association of Neuropilin-1 and MUC1 in Pancreatic Ductal Adenocarcinoma: Role in Induction of VEGF Signaling and Angiogenesis
por: Zhou, Ru, et al.
Publicado: (2016)

Differences in MUC4 Expression in Pancreatic Cancers and Pancreatic Cysts in Egypt
por: Etekpo, Asserewou, et al.
Publicado: (2018)

Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
por: Haridas, Dhanya, et al.
Publicado: (2011)

Targeting MUC4 in pancreatic cancer: miRNAs
por: Jonckheere, Nicolas, et al.
Publicado: (2015)

Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer
por: Fan, Yue, et al.
Publicado: (2020)

MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge
por: Roulois, David, et al.
Publicado: (2013)

Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases
por: Zhou, Wentao, et al.
Publicado: (2020)

MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
por: Kumari, Sonam, et al.
Publicado: (2018)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours
por: Westgaard, Arne, et al.
Publicado: (2009)

ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
por: Sharma, Sai Kiran, et al.
Publicado: (2022)

MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer
por: Radhakrishnan, Prakash, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ntvo6ucsc1u1mhqmmff2jb6d7t